Skip to main
Help and resources
Register
for My Account
Sign in
to My Account
Search
Australian Government
Federal Register of Legislation
Site navigation
Constitution
Acts
Legislative instruments
Notifiable instruments
Gazettes
Administrative Arrangements
Prerogative instruments
Norfolk Island
Home
Legislative instruments
Repealed
Text
Details
Authorises
Downloads
All versions
Interactions
Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 1) 2023
No longer in force
Click for more info
Administered by
Department of Health, Disability and Ageing
This item is authorised by the following title:
Private Health Insurance Act 2007
Superseded version
View latest version
Order print copy
Save this title to My Account
Set up an alert
F2023L00796
17 June 2023
-
31 August 2023
Legislation text
View document
Select value
Legislative instrument
Explanatory statement
Filter active
Table of contents
Enter text to search the table of contents
Collapse
Volume 1
Collapse
Part 1—Preliminary
1 Name
2 Commencement
3 Authority
4 Definitions
5 Meaning of medical device
Collapse
Part 2—Benefit requirements for private health insurance policies that cover hospital treatment and hospital substitute treatment
6 Listing of medical devices and human tissue products
7 Circumstances in which listed items are provided—other than circumstances in which a medicare benefit is payable
8 Conditions to be satisfied in relation to the provision of listed items
9 Benefits for listed items provided as part of hospital treatment
10 Benefits for listed items provided as part of hospital substitute treatment
Collapse
Part 3—Listing criteria
11 Purpose
12 General listing criteria
13 Listing criteria for medical devices to be listed in Part A of Schedule 1
14 Listing criteria for human tissue products to be listed in Part B of Schedule 1
15 Listing criteria for medical devices to be listed in Part C of Schedule 1
Collapse
Part 4—Cost recovery fees
Collapse
Division 1—Cost recovery fees relating to medical devices
16 Cost recovery fees that may be charged
17 Clinical assessment fee
18 Economic assessment fee
19 Full health technology assessment pathway fee
Division 2—Payment of cost recovery fees
20 When cost recovery fee must be paid
21 Person liable to pay cost recovery fee
Division 3—Refunds and waiver of cost recovery fees
22 Refunds
23 Waiver of cost recovery fees
Division 4—Review
24 Reviewable decisions
25 Notice of review rights
26 Internal review of decisions made by delegates
27 Notice of overpayment as a result of a review decision
Collapse
Part 5—Miscellaneous
28 Minister may have regard to recommendations and advice
29 Repeal of Part D of Schedule 1
Schedule 1—Listed medical devices and human tissue products
Volume 2
